Drugs in the Pipeline
The FDA has granted Fast Track designation to intravenous choline chloride (Protara Therapeutics), an investigational phospholipid substrate replacement therapy for the treatment of intestinal failure-associated liver disease.
Supplementation with taurine, the additive found in many energy drinks, may improve the symptoms in young people suffering a first episode of psychosis (FEP), according to a new study presented at the International Early Psychosis Association (IEPA) meeting. Taurine, an amino acid naturally occurring in the body, exhibits an inhibitory neuro-modulatory effect in the nervous…
A daily dose of beetroot juice was found to significantly improve exercise endurance and blood pressure in elderly patients.
A recently published case study details the first known incidence of sulfa hypersensitivity in primary HIV.
A 48-year-old woman with multiple sclerosis (MS) experienced acute symptomatic sinus bradycardia after receiving high-dose intravenous corticosteroid therapy, also known as pulse steroid therapy (PST), for treatment of an acute MS flare.